Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment

JCO Precis Oncol. 2021 Mar 11:5:PO.20.00370. doi: 10.1200/PO.20.00370. eCollection 2021 Mar.

Nazanin Aghel^{1

2}, Dakota Gustafson^{3

4}, Ashley Di Meo⁵, Milena Music⁵, Ioannis Prassas⁵, Michael A Seidman⁶, Aaron R Hansen⁷, Paaladinesh Thavendiranathan^{1

8}, Eleftherios P Diamandis^{4

5

9

10}, Diego Delgado¹, Jason E Fish^{1

3

4}

¹ Division of Cardiology, Peter Munk Cardiac Centre, Toronto General Hospital, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, Toronto, ON, Canada.
² Division of Cardiology, Cardio-oncology Program, Juravinski Hospital, McMaster University, Hamilton, ON, Canada.
³ Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
⁴ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
⁵ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
⁶ Laboratory Medicine Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
⁷ Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
⁸ Joint Division of Medical Imaging, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
⁹ Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
¹⁰ Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada.

No abstract available

Publication types